Etravirine

FDA Approved: * June 14, 2021
Pharm Company: * AMNEAL
Category: HIV / AIDS

Etravirine (ETR,[1] brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.[2] Etravirine is marketed by Janssen, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for pati... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Etravirine 100 mg Oral Tablet
NDC: 42291-473
Labeler:
Avkare
Etravirine 200 mg Oral Tablet
NDC: 42291-474
Labeler:
Avkare
Etravirine 25 mg Oral Tablet
NDC: 60219-1720
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 100 mg Oral Tablet
NDC: 60219-1721
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 200 mg Oral Tablet
NDC: 60219-1722
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 25 mg Oral Tablet
NDC: 69238-1720
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 100 mg Oral Tablet
NDC: 69238-1721
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 200 mg Oral Tablet
NDC: 69238-1722
Labeler:
Amneal Pharmaceuticals Ny LLC
Etravirine 100 mg Oral Tablet
NDC: 69315-285
Labeler:
Leading Pharma, LLC
Etravirine 200 mg Oral Tablet
NDC: 69315-286
Labeler:
Leading Pharma, LLC

Related Brands

Drugs with the same active ingredients